Standards & Guidelines

 Standards and Guidelines

 

Best Practice Guidelines : Continuous subcutaneous insulin infusion (CSII) A clinical guide for adult diabetes services (2018)

A group of clinicians with expertise in continuous subcutaneous insulin infusion (CSII) from across the UK have been meeting regularly to discuss and share their best practice. Insulin Pumps Wales were delighted to be  involved in these discussions and as a result of working collaboratively with the Diabetes Technology Network- UK (DTN-UK)  the UK Best Practice Guide for CSII (Insulin Pump Therapy) was produced. These guidelines are now the Standard for Wales and will help promote improvements in the care, outcomes and experience of people living with diabetes on insulin pump therapy.

 

 

 

Download the PDF 

(opens new window)

 

  Best Practice Guide: Continuous subcutaneous insulin infusion (CSII) - A guide to service requirements

This document which is comprehensive in its scope not only provides a way forward for teams and clinicians in starting the CSII services in their patch but also in benchmarking their services so that further progress and improvements can be made, where CSII services are already established. Insulin Pumps Wales were delighted to be partners in the production of this document. 

 

Download the PDF 

(opens new window)

Guidelines for managing continuous subcutaneous insulin infusion (CSII, or ‘insulin pump’) therapy in hospitalised patients

Guidelines and information developed by the Diabetes Technology Network which supports the continued use of CSII during the inpatient stay and where appropriate encourages health care professionals to allow the person with diabetes to manage their own pump therapy. The most important messages are the early involvement of the inpatient diabetes team in all scenarios and the recognition that most pump users are more than capable of managing their insulin pump therapy provided they are well enough to do so. 

 

*Coming soon- Our Non-specialist module which will embrace the guidelines above and help support healthcare professional colleagues to better accommodate and support patients on CSII therapy whilst in their care- launching in 2018*

 

Download the PDF 

(opens new window)

 Diabetes Delivery Plan for 2016-2020

We want the people of Wales to have every possible chance of minimising their risk of developing diabetes. We also want to ensure that those affected by it have timely access to high quality services. The delivery plan explains how we will achieve this.

 

Download the PDF

National Institute for Health and Care Excellence (NICE) Guidelines, Technology Appraisals and Recommendations

Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus. Technology appraisal guidance [TA151]
Published date: 23 July 2008

Link coming soon!

Type 1 diabetes in adults: diagnosis and management. NICE guideline [NG17]
Published date: August 2015
Last updated: July 2016

Download the PDF

Diabetes (type 1 and type 2) in children and young people: diagnosis and management. NICE guideline [NG18]
Published date: August 2015
Last updated: November 2016

Download the PDF

FreeStyle Libre for glucose monitoring. Medtech innovation briefing [MIB110]
Published date: July 2017
Last updated: September 2017
Download the PDF

MiniMed 640G system with SmartGuard for managing blood glucose levels in people with type 1 diabetes. Medtech innovation briefing [MIB51]
Published date: February 2016

 

Integrated sensor-augmented pump therapy systems for managing blood glucose levels in type 1 diabetes (the MiniMed Paradigm Veo system and the Vibe and G4 PLATINUM CGM system) Diagnostics guidance [DG21]
Published date: February 2016

Download the PDF